Q&A: Vaccine Researcher David Diemert, MD

The Delta variant of the SARS-CoV-2 virus is causing a surge in COVID-19 cases globally, including in the United States, where there has been a sharp increase in reported cases. The Clinical Director of the GW Vaccine Research Unit, Dr. David Diemer, discusses the Delta Variant and the Fourth Wave of the COVID-19 Pandemic. Take a look at this article to see what Dr. Diemert has to say 

Latest News

Dr. David Diemert, the director of the George Washington University Vaccine Research Unit, weighs in on President Donald Trump's executive order pushing for revisions to how children in the US are vaccinated and what that means for the future.
The GW VRU is a site for a clinical trial to examine Pfizer's new C. diff vaccine.
This was a phase 2, randomized, open-label, non-placebo controlled trial to evaluate two partial doses o the Modified Vaccinia Ankara-Bavarian Nordin (MVA-BN) vaccine for protection against mpox.